Physician profile
Devon E Fromer
NPI 1750877502
$6,003.21
in general payments reported to CMS, 2019-2025
24 companies · $587 in 2025
The $587 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,422 · 2023: $2,359 · 2024: $1,636 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,670 · Travel and Lodging: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,669.85 |
| Travel and Lodging | $911.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,127.10 | 2022-2024 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $967.53 | 2022-2025 | Endurant Iis, Valiant Captivia |
| Silk Road Medical, INC. | $587.68 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $483.37 | 2022-2025 | Afx2 Bifurcated Endograft System, Endocross Device, Torus Stent Graft System |
| Inari Medical, INC. | $395.32 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $265.53 | 2024-2025 | Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Eluvia |
| Smith+Nephew, INC. | $170.17 | 2024-2025 | Stravix, Stravix Pl, Oasis |
| Penumbra, INC. | $153.32 | 2022 | |
| Balt USA, LLC | $150.63 | 2022-2024 | Prestige Coil System |
| Intuitive Surgical, INC. | $123.25 | 2023 | Da Vinci Surgical System |
| Baxter Healthcare | $115.33 | 2023-2024 | Perclot, Preveleak |
| Shockwave Medical, INC | $80.62 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Hartmann USA, INC. | $51.22 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Janssen Pharmaceuticals, INC | $50.88 | 2022-2024 | Xarelto |
| Angiodynamics, INC. | $44.51 | 2025 | Auryon Laser System 100-120 Vac |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $37.73 | 2024 | Restrata Wound Matrix |
| Teleflex LLC | $36.95 | 2024 | Manta |
| Cvrx, INC. | $34.15 | 2023 | Barostim Neo System |
| Urgo Medical North America, LLC | $32.99 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Lemaitre Vascular, INC. | $27.25 | 2024 | Artegraft Vascular Graft |
| Ethicon US, LLC | $23.98 | 2024 | Ethicon, Surgicel Nu-Knit, Prolene |
| Laminate Medical Technologies INC. | $18.30 | 2025 | Vasq |
| Sirtex Medical INC | $12.97 | 2024 | Sir-Spheres Microspheres |
| Terumo Medical Corporation | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Fromer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.